689 related articles for article (PubMed ID: 3878791)
1. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
2. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
3. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
Pawelec G; Schneider EM; Müller C; Wernet P
Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
[TBL] [Abstract][Full Text] [Related]
5. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
6. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity.
Bontrop R; Ottenhoff T; Van Miltenburg R; Elferink D; De Vries R; Giphart M
Eur J Immunol; 1986 Feb; 16(2):133-8. PubMed ID: 3485528
[TBL] [Abstract][Full Text] [Related]
8. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines.
Santamaria P; Boyce-Jacino MT; Lindstrom AL; Rich SS; Faras AJ; Barbosa JJ
J Immunol; 1991 Mar; 146(6):1822-8. PubMed ID: 1706381
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
11. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
[TBL] [Abstract][Full Text] [Related]
12. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
[TBL] [Abstract][Full Text] [Related]
13. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
15. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
Pesando JM; Graf L; Hoffman P
J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
[TBL] [Abstract][Full Text] [Related]
16. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
Robbins PA; Maino VC; Warner NL; Brodsky FM
J Immunol; 1988 Aug; 141(4):1281-7. PubMed ID: 3135327
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex restriction of tetanus toxoid-specific human T lymphocyte clones.
Schmitt C; Cogné M; Agrapart M; Ballet JJ
Eur J Immunol; 1984 Dec; 14(12):1131-6. PubMed ID: 6083872
[TBL] [Abstract][Full Text] [Related]
18. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
Merkenschlager M; Altmann DM; Ikeda H
J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
[TBL] [Abstract][Full Text] [Related]
19. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
Fischer H; Dohlsten M; Lindvall M; Sjögren HO; Carlsson R
J Immunol; 1989 May; 142(9):3151-7. PubMed ID: 2785135
[TBL] [Abstract][Full Text] [Related]
20. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
